These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 17079010)
1. (Poly)acrylonitrile-based hydrogel as a therapeutic bulking agent in urology. Ramseyer P; Meagher-Villemure K; Burki M; Frey P Biomaterials; 2007 Feb; 28(6):1185-90. PubMed ID: 17079010 [TBL] [Abstract][Full Text] [Related]
2. In vivo study of an injectable poly(acrylonitrile)-based hydrogel paste as a bulking agent for the treatment of urinary incontinence. Ramseyer P; Micol LA; Engelhardt EM; Osterheld MC; Hubbell JA; Frey P Biomaterials; 2010 Jun; 31(17):4613-9. PubMed ID: 20303170 [TBL] [Abstract][Full Text] [Related]
3. Pilot study of two new injectable bulking agents for the treatment of faecal incontinence. Maeda Y; Vaizey CJ; Kamm MA Colorectal Dis; 2008 Mar; 10(3):268-72. PubMed ID: 17655723 [TBL] [Abstract][Full Text] [Related]
4. A new bulking agent (polyacrylamide hydrogel) for treating stress urinary incontinence in women. Lose G; Mouritsen L; Nielsen JB BJU Int; 2006 Jul; 98(1):100-4. PubMed ID: 16831152 [TBL] [Abstract][Full Text] [Related]
5. Submucosal injection of poly(lactic-co-glycolic acid) microspheres in rabbit bladder as a potential treatment for urinary incontinence and vesicoureteral reflux: preliminary results. Cho ER; Kang SW; Park HJ; Cho YS; Lee YS; Kim JC; Kim BS J Biomater Sci Polym Ed; 2005; 16(9):1109-20. PubMed ID: 16231602 [TBL] [Abstract][Full Text] [Related]
6. Tissue integration of polyacrylamide hydrogel: an experimental study of periurethral, perivesical, and mammary gland tissue in the pig. Christensen LH; Nielsen JB; Mouritsen L; Sørensen M; Lose G Dermatol Surg; 2008 Jun; 34 Suppl 1():S68-77; discussion S77. PubMed ID: 18547185 [TBL] [Abstract][Full Text] [Related]
7. Novel injectable urethral bulking agents for the treatment of urinary incontinence. Jordan O; Doelker E; Defabiani N; Caviezel A; Iselin C J Mater Sci Mater Med; 2004 Apr; 15(4):519-22. PubMed ID: 15332628 [TBL] [Abstract][Full Text] [Related]
8. Endoscopic substances for the treatment of vesicoureteral reflux. Joyner BD; Atala A Urology; 1997 Oct; 50(4):489-94. PubMed ID: 9338720 [TBL] [Abstract][Full Text] [Related]
9. Macro/Nano-gel composite as an injectable and bioactive bulking material for the treatment of urinary incontinence. Park KM; Son JY; Choi JH; Kim IG; Lee Y; Lee JY; Park KD Biomacromolecules; 2014 Jun; 15(6):1979-84. PubMed ID: 24739122 [TBL] [Abstract][Full Text] [Related]
10. Development of new injectable bulking agents: biocompatibility of radiopaque polymeric microspheres studied in a mouse model. Emans PJ; Saralidze K; Knetsch ML; Gijbels MJ; Kuijer R; Koole LH J Biomed Mater Res A; 2005 Jun; 73(4):430-6. PubMed ID: 15900614 [TBL] [Abstract][Full Text] [Related]
11. The Extended Utilization of Bulking Agents in Pediatric Urology. Weinstein C; Kirsch A Curr Urol Rep; 2024 Sep; 25(9):233-239. PubMed ID: 38888873 [TBL] [Abstract][Full Text] [Related]
12. The effect of redox polymerisation on degradation and cell responses to poly (vinyl alcohol) hydrogels. Mawad D; Martens PJ; Odell RA; Poole-Warren LA Biomaterials; 2007 Feb; 28(6):947-55. PubMed ID: 17084445 [TBL] [Abstract][Full Text] [Related]
13. Urethral bulking with polymethylmethacrylate microspheres for stress urinary incontinence: tissue persistence and safety studies in miniswine. Lemperle G; Lappin PB; Stone C; Lemperle SM Urology; 2011 Apr; 77(4):1005.e1-7. PubMed ID: 21333337 [TBL] [Abstract][Full Text] [Related]
14. Endoluminal ultrasonographic and histologic evaluation of periurethral collagen injection. Rivas DA; Chancellor MB; Liu J-B ; Hanau C; Bagley DH; Goldberg B J Endourol; 1996 Feb; 10(1):61-6. PubMed ID: 8833731 [TBL] [Abstract][Full Text] [Related]
16. Self-actuated, thermo-responsive hydrogel valves for lab on a chip. Wang J; Chen Z; Mauk M; Hong KS; Li M; Yang S; Bau HH Biomed Microdevices; 2005 Dec; 7(4):313-22. PubMed ID: 16404509 [TBL] [Abstract][Full Text] [Related]
17. Drug-sensing hydrogels for the inducible release of biopharmaceuticals. Ehrbar M; Schoenmakers R; Christen EH; Fussenegger M; Weber W Nat Mater; 2008 Oct; 7(10):800-4. PubMed ID: 18690239 [TBL] [Abstract][Full Text] [Related]
18. Bioimaging of dexamethasone and TGF beta-1 and its biological activities of chondrogenic differentiation in hydrogel constructs. Na K; Kim S; Sun BK; Woo DG; Yang HN; Chung HM; Park KH J Biomed Mater Res A; 2008 Nov; 87(2):283-9. PubMed ID: 18181092 [TBL] [Abstract][Full Text] [Related]
19. Urethral injection therapy: what is the mechanism of action? Klarskov N; Lose G Neurourol Urodyn; 2008; 27(8):789-92. PubMed ID: 18642372 [TBL] [Abstract][Full Text] [Related]
20. Use of periurethral injections of polyacrylamide hydrogel for treating post-vesicovaginal fistula closure urinary stress incontinence. Krause HG; Lussy JP; Goh JT J Obstet Gynaecol Res; 2014 Feb; 40(2):521-5. PubMed ID: 24118674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]